Updated:
Merck China
Merck China is a private equity based in Shanghai; the Altss profile covers its classification, headquarters, registration, AUM band, and key contacts for...
Merck China
Merck China is a private equity firm based in Shanghai, China. It focuses on venture capital investments. The firm has approximately 5000 employees.
General information
Firm type
Private Equity
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Sector focus
Frequently asked questions
How is Merck China structured relative to the global parent company?
Merck China operates as the Shanghai-based corporate venture capital office of Merck KGaA, Darmstadt, Germany. It is not a separate legal entity but a strategic investment function embedded within the parent company's operations in China. The team invests directly from the corporate balance sheet rather than managing third-party capital.
What investment stages does Merck China target?
The firm focuses on Seed-stage investments, specifically targeting early-stage companies where scientific and technical risk remains high but aligns with Merck's internal R&D priorities. This early entry point allows the parent company to shape development pathways and secure optionality on emerging technologies.
Which sectors does Merck China explicitly avoid?
The investment mandate maps directly to the parent company's three business sectors — Life Science, Healthcare, and Electronics. Sectors such as consumer internet, general enterprise software, or financial technology fall outside this strategic scope and are not targeted for investment.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: